Hangzhou Aichek Medical Technology Co.,Ltd

Hangzhou Aichek Medical Technology Co.,Ltd

Manufacturer from China
Active Member
4 Years
Home / Products / Uncut Sheet Rapid Test /

ODM Dengue IGg IGm Rapid Test Sheet Antibody Uncut Sheet

Contact Now
Hangzhou Aichek Medical Technology Co.,Ltd
City:hangzhou
Province/State:zhejiang
Country/Region:china
Contact Person:MrEdward YU
Contact Now

ODM Dengue IGg IGm Rapid Test Sheet Antibody Uncut Sheet

Ask Latest Price
Video Channel
Brand Name :Aichek
Model Number :DEN-A01
Certification :CE
Place of Origin :China
MOQ :5000 Test
Price :negotiable
Payment Terms :T/T
Supply Ability :negotiable
Packaging Details :40box/carton
Storage :2℃-30℃
Sample Type :Blood
User :Professional
Accuracy :99.6% (97.7%-99.9%)
Certificate :CE ISO 13485
OEM :OEM customized packing avaliable
Formats :25T/box 1T/box
After-sales Service :Available
Key words :Dengue Iggigm Antibody Rapid Test uncut sheet
For the crowd :Preliminary screening of infected people
more
Contact Now

Add to Cart

Find Similar Videos
View Product Description

Infection Disease Dengue iggigm Antibody Rapid Test with CE certificate uncut sheet

Product Name

Dengue IggIgm Antibody Rapid Test uncut sheet

Formats Strip(3mm)Device(4mm) uncut sheet
Place of Origen China
Specimen Blood
Read Time 15 minutes
Shelf life 2 years
Package uncut sheet
Storage 2℃-30℃

For professional in vitro diagnostic use only.

INTENDED USE

The Dengue IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG anti–dengue virus and IgM anti-dengue virus in human whole blood, serum or plasma. It is intended to be used by the professionals as a screening test and as an aid in the diagnosis of infection with dengue viruses. Any reactive specimen with the Dengue IgG/IgM Rapid Test must be confirmed with alternative testing method(s).

PRINCIPLE

The Dengue IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of Dengue antibodies in whole blood, serum, or plasma. This test consists of two components, an IgG component and an IgM component. In the IgG component, anti-human IgG is coated in test line region 1 of the test. During testing, the specimen reacts with Dengue antigen-coated particles in the test strip. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgG in test line region 1. If the specimen contains IgG antibodies to Dengue, a colored line will appear in test line region 1. In the IgM component, anti-ligand is coated in test line region 2 of the test. During testing, the specimen reacts with ligand anti-human IgM. Dengue IgM antibodies, if present in the specimen, reacts with the ligand anti-human IgM and the Dengue antigen-coated particles in the test strip, and this complex is captured by the anti-ligand, forming a colored line in test line region 2.

Therefore, if the specimen contains Dengue IgG antibodies, a colored line will appear in test line region 1. If the specimen contains Dengue IgM antibodies, a colored line will appear in test line region 2. If the specimen does not contain Dengue antibodies, no colored line will appear in either of the test line regions, indicating a negative result. To serve as a procedural control, a colored line will always appeared in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.

PERFORMANCE CHARACTERISTICS

1. Clinical Performance For IgM Test

A total of 314 patient samples from susceptible subjects were tested by the Dengue IgG/IgM Rapid Test and by a reference EIA. Comparison for all subjects is showed in the following table:

Dengue IgG/IgM Rapid Test
IgM EIA Test Positive Negative Total
Positive 31 1 32
Negative 3 279 282
Total 34 280 314

Relative Sensitivity: 96.9%, Relative Specificity: 98.9%, Overall Agreement: 98.7%

2. Clinical Performance For IgG Test

A total of 326 patient samples from susceptible subjects were tested by the Dengue IgG/IgM Rapid Test and by a reference EIA. Comparison for all subjects is showed in the following table:

Dengue IgG/IgM Rapid Test
IgG EIA Test Positive Negative Total
Positive 36 1 37
Negative 2 287 289
Total 38 288 326

Relative Sensitivity: 97.3%, Relative Specificity: 99.3%, Overall Agreement: 99.1%

Inquiry Cart 0